Reminds me of Paul Keating calling John Hewson Mr Magoo because he thought he lacked vision. I can’t help but think that Alterity are lacking vision given their response to your query.I will have to respectfully disagree with you on this. Whilst i believe that the University of Queensland (UoQ) is still doing great work in the field of antimicrobial resistance, it is now up to Alterity to commercialise UoQ’s novel zinc ionophore technology in conjunction with PBT2. UniQuest’s role has largely finished. In the Alterity’s announcement on 21 Dec 20, it was UniQuest who granted access to Alterity for the use of UoQ’s zinc ionophore technology. Until recently, i was allowing for the possibility that Alterity was waiting for more research by UoQ before going to the FDA for guidance but this does not seem to be the case.
- Forums
- ASX - By Stock
- ATH
- PBT2 for Middle Ear Infections
PBT2 for Middle Ear Infections, page-19
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $2.017K | 651.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 55391134 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 128926244 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 55391134 | 0.003 |
47 | 83172597 | 0.002 |
23 | 126360100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 128926244 | 20 |
0.005 | 22242406 | 25 |
0.006 | 14067472 | 17 |
0.007 | 47726651 | 22 |
0.008 | 22367732 | 22 |
Last trade - 15.24pm 04/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |